期刊文献+

肿瘤侵犯相关蛋白自分泌运动因子在瘢痕疙瘩中的表达 被引量:3

Expression of atuocrine motility factor in keloid
下载PDF
导出
摘要 背景:肿瘤侵犯相关蛋白自分泌运动因子在肿瘤细胞中表达量增高,并可增强肿瘤细胞的生长、侵犯和转移能力,而瘢痕疙瘩具有恶性肿瘤生物学特性。目的:了解肿瘤侵犯相关蛋白自分泌运动因子在人体瘢痕疙瘩、增生性瘢痕、生理性瘢痕组织中的表达情况。方法:生理性瘢痕、增生性瘢痕、瘢痕疙瘩患者各20例,切取3种瘢痕组织;用组织免疫荧光染色法观测3种瘢痕组织中自分泌运动因子的分布及相对表达量;用蛋白质免疫印迹法和荧光定量PCR检测3种瘢痕组织中的自分泌运动因子蛋白水平和基因水平的表达。结果与结论:在组织水平、蛋白水平、基因水平上,生理性瘢痕和增生性瘢痕组织中自分泌运动因子的表达较低,且二者分布及相对表达量差异无显著性意义,而瘢痕疙瘩组织中,自分泌运动因子在3个水平上的表达强度明显增高,与前二者比较差异有显著性意义(P<0.01)。结果提示自分泌运动因子与瘢痕疙瘩的肿瘤生物学特征有着密切的关系。 BACKGROUND: Autocrine motility factor (AMF) exhibits an improved expression in tumor cells, and it can enhance cell growth, invasion and metastasis. But keloid has biological characteristics of malignant tumor. OBJECTIVE: To know about the expression of AMF in keloid, hypertrophic scar and normal scar tissues. METHODS: Each 20 cases of keloid, hypertrophic scar and normal scar were studied, and three kinds of scar tissues were selected. The distribution and relative expression of AMF in the three kinds of scar tissues were assessed by immunofluorescence. Protein and mRNA level of AMF in scar tissues were analyzed by western blot and real-time PCR methods. RESULTS AND CONCLUSION: In tissue, protein and mRNA levels, normal scar and hypertrophic scar tissues showed low expression of AMF. In distribution and relative expression, there was no significant difference between the normal scar and hypertrophic scar tissues. However, the keloid tissues showed significantly higher expression of AMF than normal scar and hypertrophic scar tissues in the three levels (P 〈 0.01). These findings suggest that AMF is highly related to tumor biological characteristics of keloid.
出处 《中国组织工程研究》 CAS CSCD 2012年第20期3663-3666,共4页 Chinese Journal of Tissue Engineering Research
基金 国家自然科学基金面上项目(81071596)~~
  • 相关文献

参考文献18

  • 1Wolfram D,Tzankov A,Pülzl P. Hypertrophic scars and keloids--a review of their pathophysiology,risk factors,and therapeutic management[J].Dermatologic Surgery,2009,(02):171-181.
  • 2Butler PD,Longaker MT,Yang GP. Current progress in keloid research and treatment[J].Journal of the American College of Surgeons,2008,(04):731-741.
  • 3Yanagawa T,Funasaka T,Tsutsumi S. Novel roles of the autocrine motility factor/phosphoglucose isomerase in tumor malignancy[J].Endocrine-Related Cancer,2004,(04):749-759.
  • 4Niinaka Y,Harada K,Fujimuro M. Silencing of autocrine motility factor induces mesenchymal-to-epithelial transition and suppression of osteosarcoma pulmonary metastasis[J].Cancer Research,2010,(22):9483-9493.
  • 5Fairbank M,St-Pierre P,Nabi IR. The complex biology of autocrine motility factor/phosphoglucose isomerase (AMF/PGI) and its receptor,the gp78/AMFR E3 ubiquitin ligase[J].MOLECULAR BIOSYSTEMS,2009,(08):793-801.
  • 6Tsutsumi S,Gupta SK,Hogan V. Activation of small GTPase Rho is required for autocrine motility factor signaling[J].Cancer Research,2002,(15):4484-4490.
  • 7Tsutsumi S,Hogan V,Nabi IR. Overexpression of the autocrine motility factor/phosphoglucose isomerase induces transformation and survival of NIH-3T3 fibroblasts[J].Cancer Research,2003,(01):242-249.
  • 8Yang Y,Cheng XR,Zhang GR. Autocrine motility factor receptor is involved in the process of learning and memory in the central nervous system[J].Behavioural Brain Research,2012,(02):412-418.
  • 9Timar J,Trikha M,Szekeres K. Autocrine motility factor signals integrin-mediated metastatic melanoma cell adhesion and invasion[J].Cancer Research,1996,(08):1902-1908.
  • 10Chiu CG,St-Pierre P,Nabi IR. Autocrine motility factor receptor:a clinical review[J].Expert Review of Anticancer Therapy,2008,(02):207-217.

同被引文献41

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部